NASDAQ:CMRA

Comera Life Sciences Holdings Stock Signals

Healthcare > Biotechnology

Buy CMRA

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 22, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Comera Life Sciences Holdings, Inc.

General

	Signal Type	Signal Value	Data
	Score	0.000	84 days ( 0 %
	Last Price	$0.0001	0 %
Performance History 7 Days $0.0001 $0.0001 0% 30 Days $0.0001 $0.0001 0% 12 Mos $0.0002 $0.0001 -50.00%

3/18

Active Buy Signals

Premium Feature

Specific Signals

Short Term

Net score: 14.86

Signal Type	Signal Value	Importance	Data
High / Low	N/A	Very Low	$0.0001 - $0.0001
Trend - 3 mos	-0.00000017857143 %	High	Width: 0.00000302880194 %
Pred. range - 3 mos	$0.00009999999679 - $0.00009999999982	Low	-0.00000321025343 % - -0.00000018145144 %
Volume Direction	Sell	High	Volume: 10 · Direction: 0
Pivot Short	Sell	Very Low	Jun 18, 2026 - 2 days
RSI Short Pivot Signal	Sell	Very Low	Nov 30, -0001 - N/A days
Short MA 3 mos	Sell	Low	Nov 30, -0001 - N/A days
Long MA 3 mos	Sell	Medium	Nov 30, -0001 - N/A days
Short/Long MA 3 mos	Buy	Medium	Jun 12, 2026 - 6 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now

Long Term

Net score: 25.59

Signal Type	Signal Value	Importance	Data
Trend - 12 mos	-47.97 %	Very High	Width: 1,131.34 %
Pred. range - 12 mos	N/A - $0.0000641976888	High	-100.00 % - -35.80 %
Short MA 12 mos	Buy	Very High	Jan 29, 2026 - 99 days
Long MA 12 mos	Sell	Very High	Jun 03, 2026 - 13 days
Short/Long MA 12 mos	Sell	Very High	Jun 17, 2026 - 3 days
Pivot Long	Buy	Low	Jan 14, 2026 - 109 days
RSI Long Pivot Signal	Sell	Low	Jul 18, 2025 - 234 days
Bollinger	Sell	Medium	Nov 30, -0001 - N/A days
MACD	Neutral	High	No Dates Stored For This Signal

Notice: Technical analysis is hidden due to insufficient data.

There can be multiple reasons for our algorithm to not provide conclusion. One of them can be low or no liquidity.

If you think this is not correct, please

ABOUT COMERA LIFE SCIENCES HOLDINGS, INC.

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis dis...

Read Full Profile Here